Capsular switching in group B streptococcus CC17 hypervirulent clone: A future challenge for polysaccharide vaccine development

Journal of Infectious Diseases

Volumn 206, Issue 11, 2012, Pages 1745-1752

  Bellais, Samuel ^a,b,c   Six, Anne ^a,b,c   Fouet, Agnès ^a,b,c   Longo, Magalie ^a,b,c   Dmytruk, Nicolas ^d   Glaser, Philippe ^e,f   Trieu Cuot, Patrick ^c,e   Poyart, Claire ^a,b,c,d,e  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c CNRS   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e INSTITUT PASTEUR   (France)

^f CNRS UMR3525   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE; DNA FRAGMENT; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; CPS GENE; FRANCE; GENE SEQUENCE; GENE SWITCHING; HVGA GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; STREPTOCOCCUS AGALACTIAE;

ADULT; BACTERIAL CAPSULES; FRANCE; GENE EXPRESSION REGULATION, BACTERIAL; GENOME, BACTERIAL; HUMANS; INFANT; MULTILOCUS SEQUENCE TYPING; POLYSACCHARIDES, BACTERIAL; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84869013160     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis605     Document Type: Article

References (44)

1. Edwards MS, Nizet V. Group B streptococcal infections. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA, eds. Infectious diseases of the fetus and newborn infant. 7th ed. Elsevier Saunders USA, 2011: 419-69.
2. Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056-65.
3. Tazi A, Morand PC, Reglier-Poupet H, et al. Invasive group B streptococcal infections in adults, France (2007-2010). Clin Microbiol Infect 2011; 17:1587-9.
4. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012; 6736:61651-6.
5. Rubens CE, Wessels MR, Heggen LM, Kasper DL. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A 1987; 84:7208-12.
6. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005; 41:839-47.
7. Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009; 49:85-92.
8. Jones N, Bohnsack JF, Takahashi S, et al. Multilocus sequence typing system for group B Streptococcus. J Clin Microbiol 2003; 41:2530-6.
9. Lamy MC, Dramsi S, Billoet A, et al. Rapid detection of the highly virulent group B Streptococcus ST-17 clone. Microbes Infect 2006; 8:1714-22.
10. Lin FY, Whiting A, Adderson E, et al. Phylogenetic lineages of invasive and colonizing strains of serotype III group B streptococci from neonates: a multicenter prospective study. J Clin Microbiol 2006; 44:1257-61.
11. Manning SD, Springman AC, Lehotzky E, Lewis MA, Whittam TS, Davies HD. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol 2009; 47:1143-8.
12. Musser JM, Mattingly SJ, Quentin R, Goudeau A, Selander RK. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A 1989; 86:4731-5.
13. Tazi A, Disson O, Bellais S, et al. The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med 2010; 207:2313-22.
14. Sorensen UB, Poulsen K, Ghezzo C, Margarit I, Kilian M. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. MBio 2010; 1:1-9.
15. Brochet M, Couve E, Zouine M, et al. Genomic diversity and evolution within the species Streptococcus agalactiae. Microbes Infect 2006; 8:1227-43.
16. Brochet M, Rusniok C, Couve E, et al. Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae. Proc Natl Acad Sci U S A 2008; 105:15961-6.
17. Bohnsack JF, Whiting A, Gottschalk M, et al. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. academic centers from 1995 to 1999. J Clin Microbiol 2008; 46:1285-91.
18. Davies HD, Jones N, Whittam TS, Elsayed S, Bisharat N, Baker CJ. Multilocus sequence typing of serotype III group B Streptococcus and correlation with pathogenic potential. J Infect Dis 2004; 189:1097-102.
19. Jordan HT, Farley MM, Craig A, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008; 27:1057-64.
20. Baker CJ, Edwards MS. Group B streptococcal conjugate vaccines. Arch Dis Child 2003; 8:375-8.
21. Heath PT. An update on vaccination against group B Streptococcus. Expert Rev Vaccines 2011; 10:685-94.
22. Johri AK, Paoletti LC, Glaser P, et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006; 4:932-42.
23. Edwards MS. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccin 2008; 4:444-8.
24. Baker CJ, Rench MA, Fernandez M, Paoletti LC, Kasper DL, Edwards MS. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis 2003; 188:66-73.
25. Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007; 3:e168.
26. Weinberger DM, Trzcinski K, Lu YJ, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 2009; 5:e1000476.
27. Luan SL, Granlund M, Sellin M, Lagergard T, Spratt BG, Norgren M. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol 2005; 43:3727-33.
28. Martins ER, Melo-Cristino J, Ramirez M. Evidence for rare capsular switching in Streptococcus agalactiae. J Bacteriol 2010; 192:1361-9.
29. Poyart C, Tazi A, Reglier-Poupet H, et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 2007; 45:1985-8.
30. Al Nakib M, Longo M, Tazi A, et al. Comparison of the Diversilab(R) system with multi-locus sequence typing and pulsed-field gel electrophoresis for the characterization of Streptococcus agalactiae invasive strains. J Microbiol Methods 2011; 85:137-42.
31. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 2008; 18:821-9.
32. Glaser P, Rusniok C, Buchrieser C, et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 2002; 45:1499-513.
33. Cieslewicz MJ, Chaffin D, Glusman G, et al. Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect Immun 2005; 73:3096-103.
34. Shelver D, Rajagopal L, Harris TO, Rubens CE. MtaR, a regulator of methionine transport, is critical for survival of group B Streptococcus in vivo. J Bacteriol 2003; 185:6592-9.
35. Chaffin DO, Beres SB, Yim HH, Rubens CE. The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J Bacteriol 2000; 182:4466-77.
36. Amin A, Abdulrazzaq YM, Uduman S. Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates. J Infect 2002; 45:42-6.
37. Ekin IH, Gurturk K. Characterization of bovine and human group B streptococci isolated in Turkey. J Med Microbiol 2006; 55:517-21.
38. Palmeiro JK, Dalla-Costa LM, Fracalanzza SE, et al. Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil. J Clin Microbiol 2010; 48:4397-403.
39. Diedrick MJ, Flores AE, Hillier SL, Creti R, Ferrieri P. Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol 2010; 48:3100-4.
40. Puopolo KM, Madoff LC. Type IV neonatal early-onset group B streptococcal disease in a United States hospital. J Clin Microbiol 2007; 45:1360-2.
41. Tien N, Ho CM, Lin HJ, et al. Multilocus sequence typing of invasive group B Streptococcus in central area of Taiwan. J Microbiol Immunol Infect 2011; 44:430-4.
42. Trotter CL, Ramsay ME, Gray S, Fox A, Kaczmarski E. No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales. Lancet Infect Dis 2006; 6:616-7; author reply 7-8.
43. Tsang RS, Tsai CM, Zhu P, Ringuette L, Lorange M, Law DK. Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada. J Clin Microbiol 2004; 42:1460-5.
44. Ladhani S, Ramsay ME, Chandra M, Slack MP. No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infect Dis 2008; 8:275-6.